Arcturus Therapeutics
ARCT
#8441
Rank
NZ$0.37 B
Marketcap
NZ$13.18
Share price
0.53%
Change (1 day)
-57.32%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -NZ$0.14 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are NZ$85.14 Million. In 2024 the company made an earning of -NZ$0.17 Billion a decrease over its 2023 earnings that were of -NZ$47.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.14 Billion-18.84%
2024 -NZ$0.17 Billion240.24%
2023 -NZ$47.24 Million-298.78%
2022 NZ$23.76 M-106.79%
2021 -NZ$0.36 Billion181.83%
2020 -NZ$0.13 Billion183.72%
2019 -NZ$43.78 Million16.93%
2018 -NZ$37.44 Million154.5%
2017 -NZ$14.72 Million-65.36%
2016 -NZ$42.48 Million25.93%
2015 -NZ$33.73 Million-41.04%
2014 -NZ$57.21 Million219.64%
2013 -NZ$17.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
NZ$48.01 M-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-NZ$3.77 Million-97.12% Bahamas